9amHealth Raises $9.5M Series A Extension Led by The Cigna Group Ventures to Expand to Employers Nationwide

After Being Selected by Leading PBMs, Benefits Navigators, and Health Plans as the Virtual Cardiometabolic Provider of Choice, 9amHealth Increases the Round’s Total to $25M 9amHealth, the leading virtual provider for cardiometabolic health, announced it has raised $9.5 million in a Series A extension round today. The financing round was led by The Cigna Group Ventures, with additional support from existing institutional investors, including 7Wire Ventures, Define Ventures, Leaps by Bayer, and Founders Fund. A recent survey conducted by 9amHealth found that 48% of Americans are on or want to be on a GLP-1 medication, and a staggering 20% would even change their jobs to get access to coverage for the drugs. These life-long treatments deliver impressive clinical outcomes but come with a high price tag, putting employers and healthcare insurers under pressure. 9amHealth is addressing this challenge by providing affordable cardiometabolic care at scale and helping to manage the rising costs of GLP-1s for both patients and employers. “GLP-1s have caught the attention of Americans who have never been engaged in the healthcare ecosystem before,” said Frank Westermann, Co-Founder and Co-CEO at 9amHealth. “For the first time ever, we’re seeing a significant uptick in patients who are excited about taking care of their diabetes and weight health. But with such a high price point, employers are in need of smart solutions to manage costs and the expectat...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT 7Wire Ventures 9amHealth Craig Cimini Define Ventures Founders Fund Frank Westermann Health IT Funding Health IT Fundings Health IT Investment Leaps by Bayer The Cigna Group Ventures Source Type: blogs